ID
41371
Descripción
Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. See https://clinicaltrials.gov/ct2/show/NCT00039858 This Form is to be completed on Study Conclusion and is used to verify that no important steps were omitted. Also includes Investigator's Signature.
Link
https://clinicaltrials.gov/ct2/show/NCT00039858
Palabras clave
Versiones (1)
- 14/9/20 14/9/20 -
Titular de derechos de autor
GlaxoSmithKline
Subido en
14 de septiembre de 2020
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858
Study Completion
- StudyEvent: ODM
Descripción
Study Completion
Alias
- UMLS CUI-1
- C2348577
Descripción
If b. = YES, complete below (indicate all that apply):
Alias
- UMLS CUI-1
- C2348577
Descripción
Resolution of underlying condition requiring anticoagulation
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1514893
- UMLS CUI [1,2]
- C0277554
- UMLS CUI [1,3]
- C0449867
- UMLS CUI [1,4]
- C1514873
Descripción
Oral or subcutaneous anticoagulation therapy
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0003281
- UMLS CUI [1,2]
- C1527415
- UMLS CUI [2,1]
- C0003281
- UMLS CUI [2,2]
- C0443315
Descripción
Study drug trial period complete
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C0205197
- UMLS CUI [1,3]
- C2347804
Descripción
If b. = NO, indicate reason(s) below: (indicate all that apply)
Alias
- UMLS CUI-1
- C2348577
- UMLS CUI-2
- C1272696
Descripción
Major bleed
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C3160769
Descripción
Bleeding unresponsive to treatment
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0019080
- UMLS CUI [1,2]
- C0205269
Descripción
Interruption of infusion procedures
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C1512900
- UMLS CUI [1,2]
- C0574032
Descripción
Adverse event
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0877248
Descripción
Adverse event - specify
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C1521902
Descripción
Intercurrent Illness
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0009488
Descripción
Intercurrent Illness - specify
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C1521902
Descripción
Protocol violation
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1709750
Descripción
Protocol violation - specify
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C1709750
- UMLS CUI [1,2]
- C1521902
Descripción
Surgery
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C0543467
Descripción
Surgery - specify
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0543467
- UMLS CUI [1,2]
- C1521902
Descripción
Lack of drug efficacy | drug efficacy insuficient
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C0235828
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [2,1]
- C0598333
- UMLS CUI [2,2]
- C0231180
Descripción
Withdrawal by subject
Tipo de datos
boolean
Alias
- UMLS CUI [1]
- C1710677
Descripción
Other reason why study not completed by subject
Tipo de datos
boolean
Alias
- UMLS CUI [1,1]
- C2348577
- UMLS CUI [1,2]
- C1272696
- UMLS CUI [1,3]
- C3840932
Descripción
Other reason why study not completed by subject - specify
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C2348577
- UMLS CUI [1,2]
- C1272696
- UMLS CUI [1,3]
- C3840932
- UMLS CUI [1,4]
- C1521902
Descripción
I HAVE READ THESE CASE REPORT FORMS AND CONFIRM THAT THE INFORMATION GIVEN IS ACCURATE AND COMPLETE
Alias
- UMLS CUI-1
- C2346576
Similar models
Study Completion
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C0277554 (UMLS CUI [1,2])
C0449867 (UMLS CUI [1,3])
C1514873 (UMLS CUI [1,4])
C1527415 (UMLS CUI [1,2])
C0003281 (UMLS CUI [2,1])
C0443315 (UMLS CUI [2,2])
C0205197 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,3])
C1272696 (UMLS CUI-2)
C0205269 (UMLS CUI [1,2])
C0574032 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,2])
C1521902 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0598333 (UMLS CUI [2,1])
C0231180 (UMLS CUI [2,2])
C1272696 (UMLS CUI [1,2])
C3840932 (UMLS CUI [1,3])
C1272696 (UMLS CUI [1,2])
C3840932 (UMLS CUI [1,3])
C1521902 (UMLS CUI [1,4])
C0011008 (UMLS CUI [1,2])
Sin comentarios